Rentabilitas dodolan miturut bathi resik Revelation Biosciences Inc (REVB)

Simbol resmi perusahaan Revelation Biosciences, Inc. (REVB)

The stability of Revelation Biosciences (REVB) is constrained by the risks of failed tests and a lack of profitability. The business foundation relies on the development of immune activation agents, while financial health is sustained by institutional investments. The current net profit margin, which the GURU.Markets system illustrates in this chart, confirms high volatility, with the latest reading standing at 0.00.

Revelation Biosciences (REVB) - Margin resik saka 04.07.2022 nganti 19.11.2026

REVB (Revelation Biosciences): rincian analitis lan laporan miturut indikator

Pambiji fundamental perusahaan:Revelation Biosciences Inc - REVB
Barang unggulan Revelation Biosciences Corp

Net profit margin determines the share of profit remaining after covering all operating expenses. Analyzing historical net margins allows for the rapid identification of yield compression during shifts in market cycles. This metric measures overall resource management efficiency and the business's ability to generate free cash flow. For Revelation Biosciences (REVB), this indicator is critical due to the high risk of clinical trial failure. Negative dynamics here reflect a rapid cash burn in the absence of stable revenues.

Pesaing Revelation Biosciences (REVB)

argenx (ARGX) - Margin resik|BNTX - Margin dodolan perusahaan|ABVX (Abivax Pharma) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik ADMA Bio (ADMA)|Rentabilitas dodolan miturut bathi resik PTGX (Protagonist Therapeutics Inc)|Margin dodolan resik immunovant.com (IMVT)|Margin resik kiniksa.com KNSA|Grifols SA (GRFS) - Margin resik|Adaptive Biotechnologies Inc. - Margin dodolan resik|Margin resik Celldex Therapeutics|AUPH: Margin dodolan resik|BCRX - Margin dodolan perusahaan|VERA (Vera Corp) - Margin dodolan resik|Dianthus Pharma (DNTH) - Margin dodolan perusahaan|Margin resik Pharvaris Pharma (PHVS)|Margin dodolan resik AbCellera Corp (ABCL)|Margin dodolan resik TRML (Tourmaline Bio Inc)|Margin dodolan perusahaan precigen.com (PGEN)|PHAR - Margin resik|Tingkat bathi resik NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Rentabilitas dodolan miturut bathi resik|Zenas Corp (ZBIO) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik IMNM|GOSS: Tingkat bathi resik|Margin resik KalVista Pharma (KALV)|SEPN - Margin resik|Margin dodolan resik PVLA (pieris.com)|Margin dodolan resik Savara Pharma SVRA|RIGL: Rentabilitas dodolan miturut bathi resik|ANAB - Margin dodolan resik|ATXS: Margin dodolan resik|ENGN - Margin dodolan perusahaan|Rentabilitas dodolan miturut bathi resik RAPT|JBIO (Aerovate Therapeutics Inc) - Rentabilitas resik perusahaan|Margin dodolan resik ACRS|Rentabilitas dodolan miturut bathi resik kyvernatx.com KYTX|Margin dodolan resik TLSA (Tiziana Life Sciences, Ltd.)|Margin dodolan resik Cabaletta Bio CABA|VTYX: Rentabilitas dodolan miturut bathi resik|Theratechnologies Inc. (THTX) - Rentabilitas dodolan miturut bathi resik|AVTX: Margin dodolan resik|ELDN - Margin dodolan perusahaan|AGEN (Agenus, Inc) - Margin dodolan resik|Margin dodolan resik Climb Bio, Inc.|Margin resik Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Tingkat bathi resik|Margin dodolan resik ADAG (Adagene Inc)|IMA - Rentabilitas dodolan miturut bathi resik|STTK - Margin resik|EQ (equilliumbio.com) - Rentabilitas dodolan resik|CNTB: Margin dodolan resik|Immunic Inc (IMUX) - Margin dodolan resik|ATRA (Atara Biotherapeutics Inc) - Margin dodolan resik|Rentabilitas dodolan resik IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Tingkat bathi resik|Adicet Bio, Inc. - Rentabilitas dodolan resik|Celularity Inc - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik INmune Bio Corporation INMB|Barinthus Biotherapeutics - Margin dodolan resik|Kezar Life Sciences, Inc. (KZR) - Rentabilitas dodolan miturut bathi resik|SAB Biotherapeutics Inc. (SABS) - Margin resik|Rentabilitas dodolan miturut bathi resik Akari Therapeutics plc|Margin resik enlivex.com|q32bio.com (QTTB) - Margin dodolan perusahaan|Margin dodolan resik GOVX|Edesa Biotech, Inc. - Rentabilitas dodolan resik|iBio Inc - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik Carisma Therapeutics CARM|XTLB - Margin resik|BOLT (boltbio.com) - Rentabilitas dodolan resik|HCWB: Margin dodolan resik|Aptevo (APVO) - Margin dodolan resik|Margin resik AIM ImmunoTech|Rentabilitas dodolan miturut bathi resik Aditxt (ADTX)|Rentabilitas dodolan miturut bathi resik GRI (GRI Bio Corporation)|XORTX - Rentabilitas dodolan resik|Margin dodolan resik HIND (Vyome Holdings Inc.)|INDP: Rentabilitas dodolan resik|SCNI - Margin resik|CALI (calcimedica.com) - Rentabilitas dodolan resik|AFMD (Affimed Therapeutics) - Rentabilitas dodolan miturut bathi resik|Allakos Therapeutics (ALLK) - Margin dodolan resik|HOOK (HOOKIPA) - Margin dodolan resik|igmbio.com (IGMS) - Margin dodolan perusahaan|Margin dodolan resik ITOS|OCEA (Ocean Biomedical) - Tingkat bathi resik|Margin dodolan resik TCBP (TC BioPharm (Holdings) PLC)|THRD - Rentabilitas dodolan miturut bathi resik